SCHEMBL14835673

SCHEMBL14835673

OCC(c1ccccn1)C1CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNA5 P22460 6/20 0.40
KCNE1 P15382 2/20 0.40
TSHR P16473 1/20 0.40
FFAR2 O15552 1/20 0.39
TP53 P04637 1/20 0.39
KDM4E B2RXH2 2/20 0.38
KCNJ5 P48544 1/20 0.38
KCNJ3 P48549 1/20 0.38
SCN5A Q14524 1/20 0.38
KCND3 Q9UK17 1/20 0.38
KCNH2 Q12809 1/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 1/20 0.37
HDAC6 Q9UBN7 1/20 0.36
CYP2D6 P10635 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
CHRM2 P08172 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17064526 0.88 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL17061221 0.80 FFAR1 (0.55) SLC6A2SLC6A4SLC6A3KCNA5FFAR2
SCHEMBL28786232 0.77 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL21742088 0.76 TP53 (0.53) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL23970339 0.75 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL8599511 0.75 KCNA5 (0.44) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL22961730 0.75 KCNA5 (0.44) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL6370490 0.75 KCNA5 (0.44) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL8598551 0.75 KCNA5 (0.44) SLC6A2SLC6A4SLC6A3KCNA5KCNE1
SCHEMBL8004235 0.75 KCNA5 (0.44) SLC6A2SLC6A4SLC6A3KCNA5KCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576510-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER Amgen Inc. (US) 2013-04-10 EP disclosed
WO-2011153509-A1 PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC. (US) 2011-12-08 WO disclosed